In one paragraphArticle in Infection and immunity, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
5 authors.
Madeleine G ScottDepartment of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Wanfeng GuoDepartment of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Jon S BlevinsDepartment of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.ORCID 0000-0001-6216-7365 Kenneth T AppellDepartment of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Roger D PechousMicrobiology and Immunology, East Carolina University, Greenville, North Carolina, USA.ORCID 0000-0002-5434-4744 Funding
Defining the Role of the Plasminogen Activator Protease in the Early Events that Establish Primary Pneumonic PlagueR01AI153252 · NIAID · UNIV OF ARKANSAS FOR MED SCIS · PI HUANG, LU, PECHOUS, ROGER D · 2021 to 2025
$1.7MDefining the Role of the Plasminogen Activator Protease in the Early Events that Establish Primary Pneumonic PlagueR56AI153252 · NIAID · UNIV OF ARKANSAS FOR MED SCIS · PI PECHOUS, ROGER D · 2020 to 2020
$375kNational Institute of All AI153252NIAID NIH HHS R01 AI153252NIAID NIH HHS R56 AI153252
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Bacterial ProteinsGene Expression Regulation, BacterialPore Forming Cytotoxic ProteinsType VI Secretion SystemsYersinia pestisAnimalsHumansMicePlagueSiphonapteraVirulence FactorsBacterial ProteinsPore Forming Cytotoxic ProteinsType VI Secretion SystemsVirulence Factorsbacterial competitionBipAplaguetranslational GTPasetype 6 secretionYersiniaYersinia pestis
Identifiers
PMID40788128
PMCPMC12418749
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390